Teachers Advisors’s Intellia Therapeutics NTLA Stock Holding History

Teachers Advisors’s Portfolio NTLA Stock Details NTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$1.49M	Buy	87,213 +6,796	+8%	+$101K	﹤0.01%	2120
2018 Q4	$1.1M	Hold	80,417	–	–	﹤0.01%	2143
2018 Q3	$2.3M	Buy	80,417 +21,286	+36%	+$619K	﹤0.01%	1898
2018 Q2	$1.62M	Buy	59,131 +20,481	+53%	+$496K	﹤0.01%	2085
2018 Q1	$815K	Buy	38,650 +6,700	+21%	+$165K	﹤0.01%	2312
2017 Q4	$614K	Buy	31,950 +5,856	+22%	+$135K	﹤0.01%	2477
2017 Q3	$648K	Buy	26,094 +24	+0.1%	+$452	﹤0.01%	2466
2017 Q2	$417K	Buy	26,070 +14,991	+135%	+$209K	﹤0.01%	2681
2017 Q1	$156K	Buy	11,079 +89	+0.8%	+$1.19K	﹤0.01%	2917
2016 Q4	$144K	Hold	10,990	–	–	﹤0.01%	2962
2016 Q3	$187K	Hold	10,990	–	–	﹤0.01%	2905
2016 Q2	$235K	Buy	+10,990	New	+$292K	﹤0.01%	2806

Other funds holding NTLA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OTPPB

Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $3.46B AUM 7.79% 1-Year Est. Return

AVAI

Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Teachers Advisors's NTLA Position: Q1 2019 in Review

Teachers Advisors increased its Intellia Therapeutics (NTLA) stake by 8.5% in Q1 2019, buying an estimated $101K and bringing the position to 87,213 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2120.

Teachers Advisors first reported a position in NTLA in Q2 2016 and has held it in 12 quarters since. The position peaked at $2.3M in Q3 2018. 148 funds tracked by Wall St. Rank hold NTLA as of Q1 2019.

Teachers Advisors held 87,213 shares of Intellia Therapeutics worth $1.49M as of Q1 2019.
Teachers Advisors bought 6,796 Intellia Therapeutics shares in Q1 2019, an estimated $101K.
Intellia Therapeutics made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #2120 holding.
Teachers Advisors first reported a position in Intellia Therapeutics in Q2 2016 and has held it in 12 quarters since.
Teachers Advisors's Intellia Therapeutics position peaked at $2.3M in Q3 2018.
148 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.